0001474064-11-000057.txt : 20111109
0001474064-11-000057.hdr.sgml : 20111109
20111109160555
ACCESSION NUMBER: 0001474064-11-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111107
FILED AS OF DATE: 20111109
DATE AS OF CHANGE: 20111109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STRATEMEIER ED
CENTRAL INDEX KEY: 0001474064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 111191745
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2011-11-07
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001474064
STRATEMEIER ED
550 HILLS DRIVE
BEDMINSTER
NJ
07921
0
1
0
0
SVP & General Counsel
Stock Options
3.34
2011-11-07
4
A
0
4500
0
A
2020-02-19
Common Stock
4500
4500
D
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On November 7, 2011, the performance criteria for 4,500 of these options had been satisfied because the Issuer's Phase 3 pivotal study of NPSP558 had met the primary efficacy endpoint of a 50 percent or greater reduction in oral calcium supplementation and active vitamin D therapy and a total serum calcium concentration that was normalized or maintained compared to baseline after 24 weeks of treatment. These 4,500 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
Edward Stratemeier
2011-11-09